Identification of apple cultivars hypoallergenic for birch pollen-allergic individuals by a multidisciplinary in vitro and in vivo approach.
Mal d 1
apple
basophil activation test
birch pollen-associated food allergy
Journal
Clinical and translational allergy
ISSN: 2045-7022
Titre abrégé: Clin Transl Allergy
Pays: England
ID NLM: 101576043
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
revised:
23
06
2022
received:
23
03
2022
accepted:
19
07
2022
entrez:
29
8
2022
pubmed:
30
8
2022
medline:
30
8
2022
Statut:
ppublish
Résumé
Birch pollen-related apple allergy is the most frequent IgE-mediated food allergy in Central-Northern Europe with Mal d 1 as major allergen. Its concentration in apples varies with the cultivar and storage time. Year-round appealing, hypoallergenic cultivars still are needed to satisfy the nutritional needs of affected individuals. We characterized three promising cultivars by multidisciplinary in vitro assays including long-term storage and by clinical challenges of allergic individuals before and after the birch pollen season. Proteins were extracted from fruits of 'Santana', 'Golden Delicious' (GD), and three genuine cultivars in November 2018 and April 2019. Mal d 1-levels were analysed by mass spectrometry, SDS-PAGE, immunoblotting, competitive ELISA, and basophil activation tests. Twenty-eight allergic individuals underwent single-blinded open food challenges and skin testing with the cultivars and birch pollen in November 2018 and May 2019. Allergen-specific IgE-levels were determined. After storage all cultivars except 'Santana' were of appealing appearance and taste. Their Mal d 1 content had increased, also reflected by significantly amplified basophil activation and stronger reactions in clinical challenges. Besides, individuals showed boosted reactivity after pollen exposure indicated by enhanced allergen-specific IgE-levels and skin reactions to birch pollen. Still, all cultivars remained significantly less allergenic than GD and comparable to Santana in November 2018 in all assessments except for skin testing. Combined expertise in pomology and allergology identified promising new cultivars for allergic consumers. The evaluation of hypoallergenic apples should incorporate long-term storage and birch pollen exposure. Basophil activation tests may be suitable in the selection of promising cultivars for oral challenges.
Sections du résumé
BACKGROUND
BACKGROUND
Birch pollen-related apple allergy is the most frequent IgE-mediated food allergy in Central-Northern Europe with Mal d 1 as major allergen. Its concentration in apples varies with the cultivar and storage time. Year-round appealing, hypoallergenic cultivars still are needed to satisfy the nutritional needs of affected individuals. We characterized three promising cultivars by multidisciplinary in vitro assays including long-term storage and by clinical challenges of allergic individuals before and after the birch pollen season.
METHODS
METHODS
Proteins were extracted from fruits of 'Santana', 'Golden Delicious' (GD), and three genuine cultivars in November 2018 and April 2019. Mal d 1-levels were analysed by mass spectrometry, SDS-PAGE, immunoblotting, competitive ELISA, and basophil activation tests. Twenty-eight allergic individuals underwent single-blinded open food challenges and skin testing with the cultivars and birch pollen in November 2018 and May 2019. Allergen-specific IgE-levels were determined.
RESULTS
RESULTS
After storage all cultivars except 'Santana' were of appealing appearance and taste. Their Mal d 1 content had increased, also reflected by significantly amplified basophil activation and stronger reactions in clinical challenges. Besides, individuals showed boosted reactivity after pollen exposure indicated by enhanced allergen-specific IgE-levels and skin reactions to birch pollen. Still, all cultivars remained significantly less allergenic than GD and comparable to Santana in November 2018 in all assessments except for skin testing.
CONCLUSIONS
CONCLUSIONS
Combined expertise in pomology and allergology identified promising new cultivars for allergic consumers. The evaluation of hypoallergenic apples should incorporate long-term storage and birch pollen exposure. Basophil activation tests may be suitable in the selection of promising cultivars for oral challenges.
Identifiants
pubmed: 36036236
doi: 10.1002/clt2.12186
pmc: PMC9412969
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12186Subventions
Organisme : Danube Allergy Research Cluster
Organisme : Austrian Jubiläumsfond
ID : ÖNB17947
Organisme : Austrian Science Funds
ID : P33891 (to VI), W1212, P32953, I4437
Organisme : Medical University of Vienna
Informations de copyright
© 2022 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.
Références
J Agric Food Chem. 2016 Dec 7;64(48):9224-9236
pubmed: 27933989
Sci Rep. 2020 Jun 4;10(1):9144
pubmed: 32499528
Allergy. 2013 Sep;68(9):1196-8
pubmed: 23909986
Biom J. 2008 Jun;50(3):346-63
pubmed: 18481363
Plant Foods Hum Nutr. 2013 Dec;68(4):391-5
pubmed: 24036616
J Agric Food Chem. 2006 Aug 9;54(16):5917-23
pubmed: 16881695
J Sci Food Agric. 2014 Mar 15;94(4):798-802
pubmed: 24130074
Allergy. 2018 Oct;73(10):2046-2054
pubmed: 29654628
Allergy. 1982 Aug;37(6):437-43
pubmed: 7137538
Monogr Allergy. 1996;32:63-72
pubmed: 8813184
Eur Ann Allergy Clin Immunol. 2006 Mar;38(3):94-8
pubmed: 16752695
J Chromatogr B Biomed Sci Appl. 2001 May 25;756(1-2):19-32
pubmed: 11419712
J Agric Food Chem. 2017 Mar 1;65(8):1606-1612
pubmed: 28161953
Clin Allergy. 1987 Jan;17(1):33-42
pubmed: 3829369
J Allergy Clin Immunol. 2013 Oct;132(4):1008-10
pubmed: 23810767
J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):466-72
pubmed: 10452773
J Allergy Clin Immunol. 1995 Dec;96(6 Pt 1):960-70
pubmed: 8543755
Allergy. 2016 Feb;71(2):272-4
pubmed: 26443126
J Agric Food Chem. 2009 Nov 25;57(22):10548-53
pubmed: 19845340
J Allergy Clin Immunol. 2011 Mar;127(3):616-22.e1
pubmed: 21251701
Int Arch Allergy Immunol. 2006;141(3):230-40
pubmed: 16926543
Allergy. 2015 Sep;70(9):1079-90
pubmed: 26095197
Mol Immunol. 1993 Oct;30(15):1323-9
pubmed: 7694084
J Allergy Clin Immunol. 2006 Aug;118(2):481-8
pubmed: 16890775
Allergy. 1994 Apr;49(4):262-71
pubmed: 7518656
Ann Allergy Asthma Immunol. 2007 Dec;99(6):522-5
pubmed: 18219833
Clin Exp Allergy. 2005 Dec;35(12):1638-44
pubmed: 16393331
Allergy Asthma Immunol Res. 2018 Jul;10(4):420-424
pubmed: 29949838
J Allergy Clin Immunol. 2005 Nov;116(5):1080-6
pubmed: 16275380
BMC Plant Biol. 2013 Mar 23;13:51
pubmed: 23522122
Allergy. 2011 Apr;66(4):491-8
pubmed: 21058957
J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):679-86
pubmed: 9802379
J Allergy Clin Immunol. 2006 Jul;118(1):242-9
pubmed: 16815162
Int Arch Allergy Immunol. 2013;161(3):258-64
pubmed: 23548468
Biochem Biophys Res Commun. 1995 Sep 14;214(2):538-51
pubmed: 7677763
Ann Allergy Asthma Immunol. 2016 Oct;117(4):399-404
pubmed: 27593099
Eur J Nutr. 1999 Aug;38(4):201-15
pubmed: 10502033
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1286-1292
pubmed: 31953891
Allergo J Int. 2016;25:6-10
pubmed: 27069844
Allergy. 2021 Aug;76(8):2555-2564
pubmed: 33724487
J Allergy Clin Immunol. 2020 Oct;146(4):894-900.e2
pubmed: 32259540